论文部分内容阅读
目的探讨氨溴特罗联合复方异丙托溴铵治疗小儿毛细支气管炎的临床疗效。方法收集2013年5月至2014年5月本院收治的270例毛细支气管炎患儿资料,将患儿随机分为研究组和对照组。对照组134例患儿给予常规治疗,研究组136例患儿在此基础上给予氨溴特罗联合复方异丙托溴铵治疗,比较两组患儿治疗效果及症状消失时间。结果研究组患儿总有效率为97.1%,明显高于对照组的80.6%;且研究组患儿各症状消失时间均少于对照组,差异均有统计学意义(均P<0.05)。结论氨溴特罗联合复方异丙托溴铵治疗小儿毛细支气管炎的疗效确切,可有效缩短症状消失时间。
Objective To investigate the clinical efficacy of combining ambroxol and compound ipratropium bromide in the treatment of pediatric bronchiolitis. Methods The data of 270 children with bronchiolitis admitted from May 2013 to May 2014 in our hospital were collected. The children were randomly divided into study group and control group. The control group of 134 children given conventional treatment, the study group of 136 children on this basis, given the combination of ambroxil and ipratropium bromide treatment, the two groups of children were treated with the efficacy and symptoms disappear time. Results The total effective rate in the study group was 97.1%, which was significantly higher than that in the control group (80.6%). All the symptoms of the study group disappeared less than the control group (all P <0.05). Conclusion The combination of ambroxol and ipratropium bromide in the treatment of children with bronchiolitis is effective and can shorten the disappearance of symptoms.